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ApTrkl, a Trk-like Receptor, Mediates Serotonin-
Dependent ERK Activation and Long-Term
Facilitation in Aplysia Sensory Neurons
activated through a number of pathways in the hippo-
campus, but mechanisms regulating its activation in
Aplysia during LTF are not well characterized. PKA is
required for the translocation of ERK to the nucleus
(Martin et al., 1997b), but neither PKA nor PKC are re-
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In mammals, there is accumulating evidence support-Summary
ing a key role for receptor tyrosine kinases (RTKs) gener-
ally, and the Trk family of RTKs specifically, in synapticThe Trk family of receptor tyrosine kinases plays a
plasticity. The Trk family of RTKs and their ligands, therole in synaptic plasticity and in behavioral memory in
neurotrophins, well known for their role in neuronal dif-mammals. Here, we report the discovery of a Trk-
ferentiation, growth, and survival, have recently beenlike receptor, ApTrkl, in Aplysia. We show that it is
implicated in the induction of hippocampal LTP and inexpressed in the sensory neurons, the locus for synap-
behavioral memory in mammals (reviewed in Yamadatic facilitation, which is a cellular model for memory
et al., 2002). No Trk receptors are present in Drosophilaformation. Serotonin, the facilitatory neurotransmitter,
or C. elegans, but an invertebrate Trk receptor has beenactivates ApTrkl, which, in turn, leads to activation of
cloned from the mollusk Lymnaea stagnalis (LTrk) (vanERK. Finally, inhibiting the activation of ApTrkl with
Kesteren et al., 1998), suggesting that Trks are evolution-the Trk inhibitor K252a or using dsRNA to inhibit ApTrkl
arily ancient but have been lost in some lineages. Func-blocks the serotonin-mediated activation of ERK in the
tional studies suggest that Trk receptors are present incell body, as well as the cell-wide long-term facilitation
other invertebrate species. For example, in squid it hasinduced by 5-HT application to the cell body. Thus,
been shown that mammalian NGF induces phosphoryla-transactivation of the receptor tyrosine kinase ApTrkl
tion of a molecule that is immunogenic for anti-TrkAby serotonin is an essential step in the biochemical
antibodies (Moreno et al., 1998). In Aplysia, mammalianevents leading to long-term facilitation in Aplysia.
BDNF, the TrkB ligand, facilitates the induction of LTF,
although the receptor involved remains a mystery (Pur-Introduction
cell et al., 2003).
Here, we report the cloning and characterization ofThe marine mollusk Aplysia is an excellent model system
an Aplysia Trk-like RTK, ApTrkl, and we provide evi-in which to study the molecular and cellular basis for
dence that 5-HT activates ERK in Aplysia sensory neu-learning and memory. The most commonly studied form
rons through activation of ApTrkl and that ApTrkl is nec-of synaptic plasticity in Aplysia is long-term facilitation
essary for 5-HT-induced facilitation when 5-HT is applied(LTF), which involves serotonin (5-HT)-mediated in-
to the cell body.creases in synaptic strength between a sensory neuron
and a motor neuron. Studies of LTF have provided valu-
Resultsable insights into the mechanisms of learning and mem-
ory in many organisms, including mammals (Kandel,
Cloning2001).
Sets of degenerate PCR primers designed to target aAn example of such an insight is the finding that the
region homologous to the tyrosine kinase domains ofactivation and translocation of ERK to the nucleus are
mammalian Trks and of LTrk were used to isolate anrequired for LTF in Aplysia (Martin et al., 1997b) and
ApTrkl fragment from cDNA. The PCR product was usedalso for LTP and behavioral memory in the mammalian
to design new primers that were then employed in RACE-hippocampus (reviewed in Sweatt, 2001). ERK can be
PCR on Aplysia cDNA to isolate longer sequences, and
the process was repeated until the complete open read-
*Correspondence: wayne.sossin@mcgill.ca
ing frame was obtained (Figure 1A). Clustal analysis us-4 These authors contributed equally to this work.
ing the kinase domain revealed that ApTrkl is most simi-5 Present address: Department of Molecular and Cell Biology, Uni-
versity of California, Berkeley, Berkeley, California 94720. lar to members of the Trk family of RTKs, though the
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Figure 1. Cloning and Characterization of ApTrkl
(A)The sequence of ApTrkl is shown, and the 5UTR region is presented in nucleotides with stop codons underlined to emphasize the lack
of additional putative 5 start sites. |, glycines in glycine rich region; *, cysteines in remnant of an EGF domain, numbers for N-linked glycosylation
sites, chimera with TrkC was made at the indicated site. #, serines in serine rich domain. Sites of peptides and primers referred to in the text
are written over the relevant amino acids, and the putative transmembrane domain is underlined. The PDZ binding site at the carboxy-terminal
is shaded. Large arrows outline the kinase domain.
(B) Clustal analysis predicts that ApTrkl diverged from mammalian Trks soon after they diverged from the Ror and Musk families.
(C) Alignment of kinase domain from a number of RTKs highlights residues conserved specifically between ApTrkl and other Trks.
(D) A schematic of the receptor shows the relative size of the ecto, kinase, and carboxyl-terminal domains.
(E) Immunoprecipitation from SF9 cell lysate with either anti-P1, anti-E1, or anti-I2 antibodies, blotted with anti-I1 antibody.
(F) Immunoblot of lysate from SF9 cells expressing either Wild Type, ApTrkl, ApTrkl Y-W, or ApTrkl KR mutant with anti-I1, anti-P1, and 4g10
(anti-P-tyrosine).
(G) SF9 cells infected with baculovirus encoding ApTrkl were treated with pV or K252a and then extracts were immunoprecipitated with anti-
E1 and probed with anti-I1 and anti-P1.
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invertebrate LTrk is more similar to this family than is shown). K252a, a potent Trk kinase inhibitor, is also a
potent inhibitor of ApTrkl (Figure 1G). This pharmacolog-ApTrkl (Figures 1B and 1C). The Aplysia sequence in-
cludes the juxtamembrane NPxY signaling motif found ical profile is consistent with both the lack of homology
between the extracellular region of ApTrkl and the Trksin mammalian Trk receptors. Despite the strong homol-
ogy to Trks in the intracellular region, there was no and highly similar kinase domains.
homology in the extracellular sequence to Trks or to
other sequences in the database. We have thus named ApTrkl mRNA and Protein Are Present
the receptor ApTrkl, which stands for “Aplysia Trk-like” in the Nervous System of Aplysia
receptor. The initiating methionine is followed by a rela- To determine the expression pattern of ApTrkl in Aplysia,
tively small ectodomain including two N-linked glycosyl- we performed RT-PCR on various tissues. We found
ation sites, a glycine-rich region, and a fragment of an the greatest expression of ApTrkl mRNA in the nervous
EGF domain (Figures 1A and 1D). The ectodomain is system, as well as low-level expression in hepatopan-
followed by a single transmembrane region, a tyrosine creas, but not in other tissues (Figure 2A).
kinase domain, and a long C-terminal extension ending Western blotting using the E1 antibody in homoge-
with a putative PDZ recognition site (Figure 1D). Surpris- nates of nervous system extracts revealed prominent
ingly, there was not a clear signal peptide following ApTrkl protein expression (Figure 2B). We observed re-
the initiating methionine, and extensive 5 RACE and activity with a 110 kDa antigen that comigrates with
attempts to recover alternative splices have not revealed that seen in homogenized SF9 cell samples expressing
an extended 5 end. The sequence on the N-terminal ApTrkl. In addition to the 110 kDa band, we also noted
side of the putative transmembrane domain contains a reactivity with bands at 65 kDa, 160 kDa, and 180 kDa.
net negative charge, while that on the C-terminal side The I1 and I2 antibodies also recognized the 110 kDa
contains a net positive charge, suggesting the receptor band, but showed much greater cross-reactivity to other
is a type-I transmembrane protein inserted into the proteins than did the anti-E1 antibody (data not shown).
membrane in the correct orientation, with the C terminus The anti-P1 antibody recognized a band at 90 kDa in
inside (von Heijne, 1992). addition to the 110 kDa, 160 kDa, and 180 kDa bands
(Figure 2C). Due to the cross-reactivity with multiple
antibodies, we believe that the larger molecular weightCharacterization of ApTrkl Proteins
bands at 160 kDa and 180 kDa may be related receptorsIn order to characterize expression of ApTrkl, we raised
or alternate splice variants. We have not determinedantibodies (anti-I1, anti-I2, and anti-E1) to peptides de-
their identity, and they will not be discussed further. Therived from intracellular (I1 and I2) and extracellular (E1)
lower band at 66 kDa recognized by the anti-E1 antibodyregions of the receptor. We also generated a phospho-
may be a degradation product. The 90 kDa protein rec-peptide-specific antibody (anti-P1) to the putative sig-
ognized by anti-P1 is presumably another phosphory-naling tyrosine in the NPxY motif (P1) to monitor activa-
lated protein containing an NPxY motif similar to thattion of the receptor. To test the antibodies, ApTrkl was
of ApTrkl.expressed using baculovirus in SF9 cells. All antibodies,
including anti-P1, immunoprecipitated a band of ap-
proximately 110 kDa, which is close to the predicted ApTrkl Is Expressed in Sensory Neurons
Sensory neurons are the locus for the cellular memorymolecular mass of the amino acid sequence (94 kDa) of
the receptor (Figure 1E). A cross-reacting band of 100 underlying behavioral sensitization. To determine if
ApTrkl was expressed in sensory neurons, we per-kDa was also immunoprecipitated, but this band was
also immunoprecipitated by preimmune sera. The 110 formed immunostaining on permeabilized and nonper-
meabilized dissociated adult sensory neurons. Immuno-kDa band recognized by the antibodies was also recog-
nized by the anti-phosphotyrosine antibody 4g10. A ki- reactivity for ApTrkl was observed in both cell bodies
and neurites (Figures 2D and 2E). Surface staining innase-inactive (KR) mutant was not recognized by 4g10,
demonstrating that ApTrkl expressed in SF9 cells has the nonpermeabilized samples showed punctate immu-
noreactivity for ApTrkl in cell bodies, as well as along thetyrosine kinase activity (Figure 1F). We also expressed
a mutant with a Y-W mutation in the NPxY motif. This length of neurites. Thus, endogenous ApTrkl appears to
be expressed on the cell surface in the correct orienta-mutant was not recognized by the anti-P1 antibody,
despite immunoreactivity to 4g10 (Figure 1F). Immuno- tion, despite the lack of a signal peptide.
As anti-E1 recognized multiple bands on Westernreactivity to 4g10 is presumably due to phosphotyro-
sines present in the Trk kinase domain (Middlemas et blots, we needed to confirm that it was specific for
ApTrkl in immunohistochemistry. To determine whetheral., 1994) that are conserved in ApTrkl. The lack of P1
immunoreactivity shows specificity for the NPxY site this was the case, we knocked down expression of
ApTrkl with RNA interference (RNAi). We injected eithersince the antiphosphopeptide antibody P1 did not rec-
ognize the active site phosphotyrosines recognized ApTrkl double-stranded RNA (dsRNA) or control dsRNA
from another Aplysia RTK, Apror, into dissociated sen-by 4g10.
To investigate whether ApTrkl could be activated in sory neurons and then stained them 3 days later with the
E1 antibody. Confocal microscopy showed a significantresponse to neurotrophins, we treated SF9 cells with
commercially available neurotrophins and the tyrosine decrease in staining after ApTrkl dsRNA injection, but
not after control dsRNA injection, indicating that thephosphatase inhibitor peroxyvanadium (pV). We found
that treatment with pV strongly activated the receptor, anti-E1 antibody is largely specific for ApTrkl in sensory
cells (Figure 2F).while the neurotrophins and serotonin had no effect on
the receptor expressed in SF9 cells (Figure 1G, data not We also performed immunostaining on developmental
Neuron
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Figure 2. ApTrkl Is Expressed in Aplysia Sensory Neurons
(A) RT-PCR performed on RNA extracted from NS (nervous system), Hep (hepatopancreas), Ovo (ovotestis), Buccal (Buccal muscle), and Gill
(gill). P2 and P1 are single primer controls,  is plasmid control,  is no template. Top panel is using primers from ApTrkl and bottom is using
primers for eIF4E.
(B) Immunoblotting of homogenized nervous system (membrane fraction; Mem, 10 g), SF9 cell extract infected with ApTrkl (ApTrkl; 1 g),
or uninfected SF9 cell extract (Uninf; 1 g). Arrow indicates the presence of a 110 kDa band recognized in SF9 cells expressing ApTrkl and
in the homogenates.
(C) Anti-P1 also recognized a 110 kDa band on blot of homogenized nervous system and several other bands as well (arrows).
(D) Anti-E1 antibody recognized ApTrkl in dissociated sensory neuron cell bodies under nonpermeabilized conditions. For controls, antibody
was preincubated with peptide. For background, laser power was increased in an unused channel until some background staining was seen.
(E) Anti-E1 also recognizes ApTrkl in neurites under the same conditions.
(F) EI staining of sensory cells uninjected, double-stranded RNA from Apror (Apror dsRNA) or double-stranded RNA from ApTrkl (ApTrkl
dsRNA). Quantification of experiments with double-stranded RNA. Errors are SEM, (cover slips, cells): Uninjected, n  2,16; Apror dsRNA,
n  2,8; ApTrkl dsRNA, n  2,9. ANOVA F(30,2)  0.05, * ApTrkl dsRNA was significantly different from both other groups, Tukey’s post hoc
test, p  0.05).
(G) ApTrkl is expressed in developmental stage Aplysia sensory neurons. Whole-mount ganglia stained with anti-E1 or stained after incubation
of the anti-E1 antibody with the immunizing peptide (w/peptide). Pleural and abdominal ganglia are shown. Anti-E1 and anti-sensorin antibodies
costain neurons in pleural ganglia using confocal microscopy of whole mount ganglia.
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(stage 11) animal nervous system whole mounts. Stain- to a similar extent by each of these treatments (Figure
3C, quantitated in Figure 3D). Thus ApTrkl can be acti-ing was widespread and blocked by preincubating anti-
E1 with E1 peptide (Figure 2G). In some experiments, vated by a 5 min exposure to 5-HT and is persistently
activated during the entire length of the exposure tosamples were also stained for sensorin, an Aplysia neu-
ropeptide that is expressed exclusively in mechanosen- 5-HT.
sory neurons (Steffensen et al., 1995). Using this ap-
proach we demonstrated that sensory neurons in the
Overexpression of ApTrkl Chimera Activates ERKintact ganglia also stained with the anti-E1 antibody
but Not Akt in PC12nnr5 Cells(Figure 2G).
To determine whether ApTrkl shares any of the signaling
properties of mammalian Trk receptors, we constructed
ApTrkl Is Activated in Sensory Neurons following a chimeric receptor consisting of the extracellular do-
Treatment with Tyrosine Phosphatase main of murine TrkC and the transmembrane and intra-
Inhibitors and Serotonin cellular domains of ApTrkl. Chimeras of the KR (kinase
We next asked whether we could detect activation of inactive) and YW (no signaling tyrosine) mutant were
ApTrkl in cultures using our phosphospecific antibody designed as well, and all receptors were then expressed
(anti-P1). We applied pV to cultured sensory neurons to in mammalian PC12nnr5 cells, which do not contain Trk
reduce tyrosine phosphatase activity and immuno- receptors. Samples were either left untreated or were
stained with both anti-P1 and 4g10 (Figure 3A, quanti- treated with NT3, the TrkC ligand, homogenized, and
tated in Figure 3B). We found that pV strongly enhanced analyzed by Western blotting. Expression of the wild-
tyrosine phosphorylation, as detected by both antibod- type receptor led to an increase in ERK activation (pERK)
ies. Furthermore, the pV-enhanced anti-P1 immunore- but had little effect on Akt phosphorylation (pAkt) (Figure
activity was blocked by 100 nM K252a, suggesting that 4). Expression of the YW mutant chimera activated ERK,
phosphorylation of the receptor following pV treatment but not to the same extent as the wild-type receptor,
depends on its kinase activity (Figure 3A, quantitated and had no effect on pAkt. Finally, expression of the KR
in Figure 3B). The inhibitor did not block all phosphoryla- mutant chimera had no effect on either pathway. These
tion in the cell, since 4g10 staining was still apparent in results suggest that the chimera signals through the
samples treated with pV plus K252a (data not shown; NPxY as well as other signaling sites to activate ERK,
also see Figure 6). To confirm the specificity of the anti- but does not activate Akt. Treatment with NT3 induced
P1 antibody in these experiments, we repeated the a further increase in pERK in the WT, but not in the YW
knockdown of ApTrkl using RNAi and then treated the or KR chimeras, reaffirming that pERK signaling involves
cells with pV (Figure 3E). We saw a large decrease in the NPxY site. In control experiments NT3 strongly acti-
anti-P1 staining after ApTrkl dsRNA injection, but not vated both pERK and Akt when cells were transfected
after Apror dsRNA injection, suggesting that this anti- with TrkC, suggesting that the specificity of ApTrkl is not
body is specific for activated ApTrkl. RNAi did not affect due to properties of PC12nnr5 cells, but to differences
the level of 4g10 staining, confirming the specificity of between TrkC and ApTrkl in their intracellular domains.
the knockdown (Figures 3E and 3F). We also detected
decreases in anti-P1 staining in neurites (Figures 3G and
3H). Thus, the increase in P1 staining that is seen with Overexpression of Wild-Type but Not Kinase-
Dead ApTrkl Induces ERK Activationthe nonspecific RTK activator pV is due to activation of
ApTrkl, demonstrating the specificity of this antibody in Sensory Neurons
To extend our findings in PC12nnr5 cells to Aplysia, wefor ApTrkl in these cells. However, we did not see
changes in the basal level of anti-P1 staining, either with overexpressed WT ApTrkl and KR ApTrkl in dissociated
sensory cells. To confirm expression of the protein, weK252a alone or dsRNA. This suggests that the basal
level of receptor activation is quite low and that the first performed immunostaining using anti-E1 plus anti-
tubulin or anti-P1 plus anti-tubulin (Figure 5A). We ob-staining observed with the antibody in the absence of
activators may be nonspecific. served substantial overexpression of ApTrkl in cells in-
jected with ApTrkl DNA compared with the endogenous5-HT-induced LTF is blocked by inhibitors of tyrosine
kinase activity (Purcell et al., 2003), suggesting that 5-HT expression in uninjected cells. WT ApTrkl was strongly
activated in both cell bodies and neurites as measuredreceptor activation may activate an RTK. Various ago-
nists of G protein-coupled receptors have been shown with the P1 antibody, indicating that overexpression is
sufficient to cause dimerization and thus activation ofin several studies to lead to RTK transactivation (Daub
et al., 1996; Keely et al., 2000; Kotecha et al., 2002). We the receptor (Figure 5B). The KR mutant was not acti-
vated, thus providing further evidence that the receptortherefore investigated whether ApTrkl is activated by
5-HT. Treatment with 5-HT for 1 hr led to a significant is activated by autophosphorylation (data not shown).
We then performed immunostaining using anti-pERKincrease in ApTrkl phosphorylation that could be blocked
by application of 100 nM K252a (Figure 3A, quantitated and 4g10 (Figure 5C). Staining with anti-pERK revealed
a significant increase in pERK with WT, but not KR,in Figure 3B). We wondered whether ApTrkl could also
be activated by 5 min exposure to 5-HT, which induces suggesting that ApTrkl activates ERK in Aplysia sensory
neurons. Finally, expression of the KR mutant (as deter-short-term facilitation requiring only covalent modifica-
tion of existing proteins, or by five 5 min pulses of 5-HT mined by EGFP fluorescence) did not induce an increase
in either 4g10 or pERK staining, showing that ERK sig-over a period of 90 min, which induces LTF requiring
transcription and translation in addition to covalent naling through ApTrkl depends on the kinase activity of
the receptor.modification. We found that ApTrkl could be activated
Neuron
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Figure 3. ApTrkl Is Activated by pV and 5-HT
(A) Anti-P1 (P-Trkl) detected activation of ApTrkl following treatment with pV (2 mM H2O2 and 100 m Na-orthovanadate) or 5-HT (20 M) for
1 hr. Activation was inhibited with K252a (100 nM).
(B) Quantification of ApTrkl activation. Errors are SEM (cover slips, cells): Control (8,94); 5-HT (6,85); 5-HT  K252a (3,26); pV (4,45); pV 
K252a (4,61). ANOVA: F(307,4) 0.001. Important Tukey’s post hoc tests (*, C versus 5-HT, p  0.01; C versus pV, p  0.001; 5-HT versus
5-HT  K252a, p  0.01, pV versus pV  K252a, p  0.001).
(C) ApTrkl is activated within 5 min of exposure to 5-HT (20 M). It is activated to a similar degree whether sensory cells are exposed to 5-HT
for 5 min, 90 min, or to five 5 min pulses of 5-HT.
(D) Quantitation of anti-P1 staining. Errors are SEM (cover slips, cells): 5 min Control (2,26); 5-HT (2,21); 5 pulses C (2,29); 5-HT (2,26); 90 min
C (3,38); 5-HT (3,34). All 5-HT treatments were compared to their own control (*p  0.01 two-tailed Student’s t test).
(E) P1 (P-Trkl) and 4g10 (P-tyrosine) staining of cells uninjected, injected with double-stranded RNA from Apror (Apror dsRNA), or injected
with double-stranded RNA against ApTrkl (ApTrkl dsRNA). All cells were treated with pV as in (A).
(F) Quantitation of effect of double-stranded RNA injection. Errors are SEM (cover slips, cells). Uninjected (3,17); Uninjected pV (3,23); Apror
dsRNA control (3,22); Apror dsRNA pV (3,22); ApTrkl dsRNA control (3,29); ApTrkl dsRNA pV (3,22). For P1 (P-Trkl) staining, ANOVA (F133,5) 
0.001. Important Tukey’s post hoc test (*, Dye C versus pV, p  0.01; Apror dsRNA C versus pV, p  0.01; pV ApTrkl dsRNA versus pV
uninjected and versus pV Apror dsRNA, p  0.01). NS, ApTrkl dsRNA C versus pV, p  0.1. For 4g10, P-tyrosine staining ANOVA F(133,5) 
0.001. All controls were different from all pVs (Tukey’s post hoc test, p  0.01). No difference with dsRNA injections under all tests (p  0.1).
(G) Neurite staining with anti-P1 (P-Trkl) after 60 min of pV treatment is also specifically reduced by dsRNA to ApTrkl, compared with dsRNA
to Apror.
(H) Errors are SEM (coverslip, cells): Apror dsRNA (1,3), ApTrkl dsRNA (1,3); *p  0.05, one-tailed Student’s t test.
Endogenous ApTrkl Is Required for ERK ited with 100 nM K252a, indicating that pV activates
ERK partly through ApTrkl. In contrast, 4g10 stainingActivation in Sensory Neurons
Because ApTrkl is expressed in sensory neurons, we induced by pV was not significantly decreased by
K252a, suggesting that the antagonist is not inhibitingwere interested in testing whether the endogenous re-
ceptor could activate ERK. First, we activated the recep- the majority of tyrosine kinases in sensory cells. RNAi
knockdown experiments were also performed to exam-tor with pV and saw robust activation of ERK (Figures
6A and 6B). This activation could be significantly inhib- ine the specificity of this effect. Indeed, pV caused signif-
5-HT Activates ApTrkl
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Figure 4. Overexpression of Chimeric Re-
ceptor Leads to ERK Activation in PC12nnr5
Cells
(A) Cells were transfected with mock vector,
TrkC-ApTrkl (WT), TrkC-ApTrkl Y-W (Y-W), or
TrkC-ApTrkl (K-R) (K-R), either in the pres-
ence () or absence () of NT3 (100 ng/ml).
Immunoblot of homogenate with P-Akt, regu-
lar Akt, P-ERK, regular ERK, anti-P1 (P-Trkl),
and anti-I1.
(B and C) Graphical representation of fold
changes in pAkt and pERK levels. Errors are
SEM, n  4. No significant changes in AKT
phosphorylation were detected. ERK was
significantly activated by both WT and Y-W
chimeras (p 0.01 compared to MOCK, two-
tailed Student’s t test). NT3 only activated the
WT chimera. (p  0.05 compared to WT with
no NT3, two-tailed Student’s t test).
icantly less activation of ERK in cells injected with ApTrkl other component is induced by 5-HT acting at the cell
body—this form of LTF is cell wide, decays to baselinedsRNA compared to cells injected with control dsRNA,
confirming that endogenous ApTrkl contributes to pV by 48 hr, and is not accompanied by growth of new
varicosities (Casadio et al., 1999; Sun and Schacher,activation of ERK (Figures 6C and 6D).
Because 5-HT causes activation of ERK (Dyer et al., 1998). As our experiments had examined changes in
ApTrkl and ERK activation in the cell bodies of sensory2003; Purcell et al., 2003) as well as activation of ApTrkl,
we wondered whether activation of ApTrkl was required neurons, we wondered whether K252a could block cell-
wide LTF induced by five pulses of 5-HT restricted tofor the activation of ERK. Cells were treated for 1 hr with
20 M 5-HT in the absence or presence of 100 nM the cell body. Indeed, K252a strongly blocked LTF when
5-HT application was restricted to the cell body (FiguresK252a. We saw a significant increase in p-ERK staining
after 5-HT treatment, confirming previous studies using 7B and 7C). To confirm that the block of LTF was due
to actions of K252a on ApTrkl, we repeated these experi-immunoblotting (Dyer et al., 2003) (Figures 6E and 6F),
and this increase was blocked by K252a. We repeated ments using dsRNA. Injections of dsRNA had no effect
on either the size of basal EPSPs or on the effects ofthese experiments using dsRNA injections of ApTrkl to
remove the receptor. After removal of ApTrkl by dsRNA, control applications (Figure 7D). Thus, for statistical
tests, the control applications for the three conditions5-HT no longer significantly increased p-ERK levels in
sensory neurons (Figures 6G and 6H). In contrast, 5-HT were pooled. Decreasing the level of ApTrkl with dsRNA
completely blocked LTF when induced by somatic appli-did activate ERK when dsRNA encoding Apror was in-
jected into sensory neurons (Figures 6G and 6H). The cation of 5-HT, while the dsRNA to Apror had no effect
on LTF induced by somatic application (Figure 7E).difference between the levels of P-ERK in Apror dsRNA
injected neurons and ApTrkl dsRNA injected neurons Poststaining of sensory neurons showed reduction of
ApTrkl staining in these experiments (Figure 8). Thesewas also significant. There was no inhibition of basal
p-ERK levels by either treatment. These results demon- results strongly confirm the earlier results with K252a,
showing that ApTrkl is required for LTF induced by somastrate that ApTrkl activation is required for 5-HT-medi-
ated activation of ERK in sensory neurons. application of 5-HT. However, in contrast to K252a that
did not block LTF after bath application of 5-HT, in neu-
rons injected with dsRNA to ApTrkl, LTF induced byApTrkl Is Required for Long-Term Facilitation
bath application was reduced by about 50%. While theBecause inhibiting ApTrkl significantly decreases 5-HT-
difference between the increase in EPSP size in themediated activation of ERK, we next sought to deter-
presence of 5-HT was not significantly different betweenmine whether receptor function was necessary for LTF.
any of the conditions (5-HT, 5-HT dsRNA Apror, 5-HTFive 5 min pulses of 5-HT bath applied over a 90 min
dsRNA ApTrkl; Tukey’s post hoc test, all p  0.1), theperiod to sensory neuron-motor neuron cocultures pro-
increase with 5-HT was significant in control (p 0.001,duced significant LTF at 24 hr. Surprisingly, LTF was
Tukey’s post hoc test) and Apror dsRNA injected neu-not blocked when K252a was present in the bath during
rons (p 0.01, Tukey’s post hoc test), but not in neurons5-HT application (Figure 7A). However, LTF induced by
treated with ApTrkl dsRNA (p  0.17, Tukey’s post hocbath application of 5-HT can be split into two compo-
test). These results suggest that ApTrkl assists, but isnents, each of which can be induced and expressed
not absolutely required for, LTF when 5-HT is bath ap-independently. One component is induced by 5-HT act-
plied. The difference between the ability of K252a anding at the sensory neuron-motor neuron synapse—this
dsRNA to inhibit LTF when 5-HT is bath applied may beform is synapse specific, lasts 72 hr, and is accompanied
by growth of new varicosities (Martin et al., 1997a). The due to other targets of K252a (see Discussion).
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Figure 5. Overexpression of ApTrkl in Aplysia Sensory Neurons Leads to ERK Activation
(A) Injection of pNEX3-ApTrkl plasmid DNA increased levels of ApTrkl as detected by anti-E1 antibody in cells expressing EGFP as compared
to uninjected cells. Anti-tubulin staining (Tubulin) shows the dimensions of the cell. pNEX3-EGFP was coinjected to verify successful injection
and expression.
(B) Overexpression led to activation of ApTrkl in expressing cells (EGFP positive) as detected by anti-P1 (P-Trkl).
(C) Overexpression of WT ApTrkl, but not KR mutant, caused increases in both P-tyrosine (4g10 staining) and P-ERK activation, indicating
that activation of the receptor was sufficient for signaling to ERK. Quantitation of overexpression studies (below). All experiments were
standardized to cells injected with vector encoding EGFP alone. EGFP alone values are not shown. Errors are SEM (cover slips, cells): ApTrkl
WT (3,43); ApTrkl K-R (3,30); Uninjected (3,15); and EGFP (3,13). Overexpression of ApTrkl significantly increased anti-P-ERK levels (ANOVA
F(97,3), p  0.001) and 4g10 staining (p  0.001). *, Tukey’s post hoc test shows ApTrkl significantly different from all other groups for both
P-ERK and 4g10 staining (p  0.01). ApTrkl and ApTrkl K-R cells had equal levels of EGFP, suggesting that their expression levels were equal
(EGFP uses the same promoter as ApTrkl in these experiments).
Discussion some of which are involved in ligand binding. These
domains are not present in ApTrkl. ApTrkl contains a
NPxY signaling motif in the juxtamembrane region thatFrom the nervous system of Aplysia californica we have
cloned an RTK, ApTrkl, that exhibits strong homology is involved in binding Shc in mammalian Trks (Obermeier
et al., 1993), leading to Ras-dependent signaling andto mammalian Trk receptors in the kinase domain, as
well as conservation of a key signaling tyrosine, but induction of ERK and Akt (van der Geer et al., 1994).
Indeed, expression of chimeric constructs of ApTrkl inpossesses a novel extracellular domain. We find that
the receptor is expressed in the sensory neurons of the heterologous cells activates ERK. Our finding that
ApTrkl does not activate Akt distinguishes it from mam-pleural ganglia. Treatment of sensory cells with 5-HT
led to activation of the receptor, and this transactivation malian Trk receptors, in which Akt phosphorylation is
also induced via the NPxY motif (Atwal et al., 2000).led to activation of ERK. Furthermore, inhibition of the
receptor blocked induction of cell-wide LTF. However, while the full consensus sequence for Shc
binding is present in most Trk receptors, including LTrk
(van der Geer et al., 1994; van Kesteren et al., 1998),Structure and Evolution
The majority of Trk receptors identified so far are from ApTrkl appears to lack the necessary hydrophobic resi-
dues N-terminal to the NPxY site (Wolf et al., 1995).vertebrates, and all have a similar structure, including
Ig and leucine-rich domains in the extracellular region, Interestingly, another docking protein, FRS2, has been
Figure 6. Activation of Endogenous ApTrkl Is Required for ERK Activation
(A) Treatment of sensory cells with pV leads to robust activation of ERK. K252a reduced this activation. In contrast, overall increase of tyrosine
phosphorylation was unaffected by K252a.
(B) Quantification of experiments in (A). Errors are SEM (coverslips, cells): Control (5,43), pV (5,74), and pV  K252a (5,59). For ERK-P ANOVA,
F(173,2) p  0.001. Tukey’s post hoc test revealed that all groups were significantly different (*p  0.05). For anti-P tyrosine (4g10) staining,
ANOVA F(173,2) p  0.001, Tukey’s post hoc test revealed that pV and pV  K252a were different from control (*p  0.01), but not different
from each other (NS, p  0.5).
(C) Injection of sensory cells with ApTrkl dsRNA decreased pV-induced ERK activation relative to cells injected with control dsRNA.
(D) Quantification of experiment in (C). Errors are SEM (coverslips, cells): ApTrkl dsRNA (3,41) and Ror dsRNA (3,31). Student’s paired t test,
p  0.01.
(E) Treatment of sensory cells with 5-HT increased activated ERK, which was blocked by K252a.
(F) Quantitation of experiments in (E). Errors are SEM (coverslips, cells): Control (3,30), 5-HT (3,64), and 5-HT  K252a (3,43). ANOVA F(134,2)
p  0.01. Tukey’s post hoc test revealed that the 5-HT group was significantly different from the other group, p  0.05.
(G) Treatment of sensory cells with 5-HT increased activated ERK in cells injected with dsRNA against Apror, but 5-HT did not increase
activated ERK in cells injected with dsRNA against ApTrkl.
(H) Quantitation of experiments in (G). Errors are SEM (coverslips, cells): Apror dsRNA control (4,11), Apror dsRNA 5-HT (4,18), ApTrkl dsRNA
control (4,14), and ApTrkl dsRNA 5-HT (4,18). ANOVA (57,3) p  0.001. Tukey’s post hoc test revealed that the Apror dsRNA 5-HT group was
significantly different from all other groups (p  0.01), and no other groups were significantly different (N.S).
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Figure 7. ApTrkl Is Required for LTF Induced by Cell Body Application of 5  5-HT, but Does Not Affect LTF Induced by Bath Application of
5  5-HT
(A) EPSP amplitude of sensory-motor synapses was measured after 4 days in vitro. Cultures were then either mock-treated or treated with
five pulses of 5-HT (10 M) given in the bath at 20 min intervals (see Experimental Procedures). K252a-treated cultures were incubated with
K252a (100 nM) for 30 min prior to, during, and 1 hr following the 5-HT applications. Control cultures were incubated with vehicle (0.1% DMSO)
during this period. EPSP amplitude was measured 24 hr later. Representative traces are shown at top; a histogram of the group data (	SEM)
is shown below; ANOVA, p  0.001. Facilitation was significant for both 5-HT and 5-HT  K252a (*p  0.01, Tukey’s post hoc test), and there
was no significant difference between these two groups (p  0.1, Tukey’s post hoc test).
(B) Cultures received five spaced pulses of 5-HT (100 M) or vehicle (0.1% fast green, mock) delivered locally to the cell body with a perfusion
electrode, as shown in (C) and as described in the Experimental Procedures. K252a-treated cultures were incubated with K252a (100 nM) in
the bath for 30 min prior to, during, and 1 hr following the 5-HT applications. Control cultures were incubated with vehicle (0.1% DMSO)
during this period. Representative traces are shown at top; a histogram of the group data (	SEM) is shown below; ANOVA, p  0.001.
Facilitation was significant for 5-HT (*p  0.01, Tukey’s post hoc test), but not for 5-HT  K252a (p  0.5, Tukey’s post hoc test). There was
a significant difference between the amount of facilitation between 5-HT and 5-HT  K252a (*p  0.01, Tukey’s post hoc test).
(C) Photomicrograph of sensory neuron (sn)-motor neuron (mn) culture with local cell body application of 5-HT. Scale bar, 100 m.
(D and E) Sensory neurons were injected 1 day after pairing with either vehicle, dsRNA directed against Apror, or dsRNA directed against
ApTrkl. EPSP amplitude of sensory-motor synapses was measured after 4 days in vitro (3 days after dsRNA injection). Cultures were then
either mock-treated or treated as above with five pulses of 5-HT (10 M) given in the bath (D) or selectively to the cell body (E). EPSP amplitude
was measured 24 hr later. Representative traces are shown at top; a histogram of the group data (	SEM) is shown below. After pooling all
the control values, ANOVA and Tukey’s post hoc tests on bath-applied 5-HT demonstrated that there was significant facilitation by 5-HT in
control (*p  0.01) and Apror dsRNA injected neurons (*p  0.05), but not in neurons injected with dsRNA to ApTrkl (p  0.17). However, the
post hoc tests also showed no significant differences in the amount of facilitation between control neurons, neurons injected with dsRNA to
ApTrkl, and neurons injected with dsRNA to Apror (NS, all p  0.1). When 5-HT was applied to the soma, ANOVA and Tukey’s post hoc tests
showed that there was significant facilitation for both control (*p  0.01) and Apror dsRNA injected neurons (*p  0.01) but not in ApTrkl
dsRNA-injected neurons (p  0.5). Moreover, there was a significant difference between the amount of facilitation in ApTrkl dsRNA-injected
neurons and the amount in control neurons and neurons injected with dsRNA to Apror (*p  0.01).
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Figure 8. ApTrkl Levels Were Reduced in the
Electrophysiology Experiment
Poststaining of sensory-motor neuron cul-
tures confirms knockdown of ApTrkl. After
measuring LTF, sensory motor neuron cul-
tures were fixed and stained with the anti-E1
antibody using the nonpermeabilized proto-
col. Low-magnification pictures are shown to
display the knockdown of ApTrkl in neurites
and the high-magnification pictures are shown
to display the knockdown in cell bodies.
shown to bind Trks through the NPxY site, resulting in agent K252a. While K252a is a potent inhibitor of the
Trk receptors in general (Tapley et al., 1992), and ApTrklactivation of the small GTPase Rap1, which mediates
prolonged activation of ERK in PC12 cells (Patapoutian in particular (Figure 1), it is also known to interfere with
activation of PKC and CaMKII (Hashimoto et al., 1991;and Reichardt, 2001). FRS2 is not known to be involved
in Akt activation (Patapoutian and Reichardt, 2001), and Kase et al., 1987). We have previously shown that PKC
is not involved in the activation of ERK by 5-HT (Dyerit seems likely that ApTrkl signals through FRS2 in mam-
malian cells. The adaptor that links ApTrkl to ERK activa- et al., 2003), and the PKC inhibitor chelerythrine does
not block LTF (Hu et al., 2003), so possible inhibition oftion in Aplysia neurons remains to be identified
It should also be noted that a second signaling tyro- PKC by K252a is unlikely to be important for our results.
CaMKII appears to negatively regulate LTF. Injecting ansine that acts through phospholipase C is also absent
in ApTrkl, although present in LTrk (van Kesteren et al., autoinhibitory peptide of CaMKII into Aplysia sensory
neurons causes an increase in short-term facilitation1998). However, while some residues that are highly
conserved among Trk receptors are missing in ApTrkl, and lowers the threshold for induction of LTF to one
pulse of 5-HT (Bartsch et al., 1998). Thus, if K252a wereseveral residues found almost exclusively in Trks are
present, suggesting that the Aplysia sequence diverged inhibiting CaMKII in our LTF experiments, we would ex-
pect the blocking effect of K252a to underrepresentfrom mammalian Trks and LTrk after Trks had diverged
from other closely related RTK families such as Ror ApTrkl’s contribution to LTF and indeed this is one pos-
sible explanation of the fact that bath-applied LTF wasand Musk.
The extracellular domain of ApTrk lacks an apparent not blocked by K252a, while it was partially blocked by
dsRNA to ApTrkl.signal sequence. Yet, the expressed receptor is active
in SF9 cells and Aplysia neurons, demonstrating that A recent paper describes a role for sensorin, a neuro-
peptide released from Aplysia sensory neurons by 5-HT,the protein is expressed in the correct orientation. While
we cannot rule out the existence of an ApTrkl ligand, it in LTF (Hu et al., 2004). The actions of sensorin are
blocked by K252a, suggesting a role for ApTrkl, or an-is possible that the main function of this protein is to
act as a complex for transactivation. This would explain other similar RTK, in mediating the actions of sensorin.
Sensorin may be a ligand for ApTrkl or may play a rolethe loss of extracellular features due to a lack of selec-
tion for a ligand binding domain. in ERK activation after ApTrkl transactivation. One ap-
parent discrepancy between the results in this manu-
script and our own is that in their experiments whenApTrkl Expression, Activation, and Signaling
ApTrkl protein was expressed in sensory neurons, which K252a was added after the first two pulses of 5-HT,
K252a did block LTF when 5-HT was applied to the bath.are well studied for their role in synaptic facilitation.
ApTrkl was activated by a single 5 min pulse of 5-HT The late addition of K252a was important for this effect
since both we and these investigators observed that(Figure 3C), raising the possibility that it may function
in the induction of a synaptic tag for sensory presynaptic incubation of K252a for the entire period of 5-HT applica-
tion did not block LTF (S. Schacher, personal communi-terminals since a 5 min pulse of 5-HT is sufficient to tag
the synapse (Martin et al., 1997a). However, one pulse cation). As described above, the inhibition of CaMKII by
K252a and the enhancement of LTF seen after CAMKIIof 5-HT does not activate ERK, which suggests that
activation of ERK by ApTrkl may require persistent acti- inhibition may explain this effect. The block of LTF by
the late addition of K252a (Hu et al., 2004) implicatesvation of the receptor. For example, Trks signal to ERK
only after endocytosis (York et al., 2000), and this may Trk-like RTKs in facilitation when 5-HT is applied to the
bath. Indeed, ApTrkl dsRNA injections decreased thenot be stimulated by short bouts of receptor activation or
may require activation of additional signaling pathways. amount of LTF seen after bath application of 5-HT, al-
though this decrease did not reach statistical signifi-Alternatively, prolonged treatments with 5-HT may re-
cruit additional signaling components that are required cance in our experiments. Further work will be required
to determine if there is a role for ApTrkl in facilitationin addition to ApTrkl for ERK activation.
Many of our experiments use the pharmacological after bath application of 5-HT. The increased sensitivity
Neuron
726
of the soma-specific LTF to ApTrkl inhibition may sug- RTKs required to stimulate facilitation (Purcell et al.,
2003), but BDNF does not activate ApTrkl. Thus, it isgest the existence of an alternative mechanism for ERK
activation outside the cell body in the processes. In- likely that additional RTKs exist in Aplysia that can also
contribute to synaptic plasticity in this system. In con-deed, synapse-specific forms of ERK activation have
been documented in vertebrate systems (Watson et al., clusion, we have identified an invertebrate RTK with
similarity to Trks that plays a physiological role in regu-2001). Alternatively, there may be signal transduction
pathways other than ERK activation that are necessary lating synaptic plasticity.
for LTF and are activated by ApTrkl in the cell body,
Experimental Proceduresbut are activated by redundant pathways outside the
cell body.
Animals
While the dsRNA experiments demonstrate that the Aplysia californica (75–125 g) were obtained from Marine Specimens
ApTrkl protein is involved in LTF, we do not know whether Unlimited (Pacific Palisades, CA), the Mariculture Facility of the Uni-
the procedure also removes the high-molecular weight versity of Miami (Miami, FL), or from Alacrity Marine Supply (Re-
dondo Beach, CA) and were maintained in an aquarium for at leastproducts recognized by the E1 antibody. If these are alter-
3 days before experimentation.native splice products of ApTrkl or very closely homolo-
gous isoforms, they may have also been removed by the
CloningdsRNA treatment and thus may contribute to LTF.
5 and 3 degenerate primers were used to amplify fragments of
Transactivation of an RTK by the 5-HT receptor has putative RTKs. The degenerate primers used were as follows: de-
not previously been shown in Aplysia. However, a role generate 5 primer (hybridizes to GEGAFG), GA(A/G) GGN GCN
for GPCRs in activating RTKs is well established. Stimu- TT(C/T) GGNAA; degenerate 3 primer (hybridizes to TRNCL), A(A/G)
(A/G)CA (A/G)TT NC(G/T) NGT.lation of Rat-1 fibroblasts with the GPCR agonists endo-
The receptor was cloned by RACE-PCR, using a Clontech Mara-thelin-1, lysophosphatic acid, and thrombin results in
thon cDNA Amplification Kit (Palo Alto, CA) according to manufac-transactivation of the epidermal growth factor receptor
turer’s instructions. The primers used to amplify the final sequence
(EGFR) and causes ERK activation (Daub et al., 1996). were as follows: specific 5 primer, CGGGATCCGGAAAACATCAA
One mechanism for the transactivation of EGFR involves TTGCTTCTCGG; specific 3 primer, CGGGGTACCCCTCTACAGCA
GPCR-mediated stimulation of membrane bound metal- ATGAATGACTCG.
The full-length sequence was first spliced into Baculovirus BB4loproteinases, which, in turn, induce the extracellular
vector (Invitrogen), using restriction sites embedded in the specificrelease of heparin binding-EGF (HB-EGF) from its latent
primer sequences above (BamHI in the 5 primer, KpnI in the 3membrane-spanning precursor in the plasma mem-
primer). Two separate clones were sequenced completely on both
brane (Prenzel et al., 1999). Another mechanism involves strands, using the services of The W.M. Keck Biotechnology Re-
intracellular, and thus ligand-independent, activation of source Laboratory (Yale University, New Haven, CT) and Bio S&T
EGFR by the tyrosine kinases Src and Pyk, which act Inc. (Montreal, QC, Canada). The WT ApTrkl-BB4 was then digested
at unique Xba1 and Kpn1 sites and ligated into equivalent sitesdownstream of GPCRs (Keely et al., 2000). Dopamine
in pNEX3.activates PDGF receptors in mammalian neurons through
a similar mechanism (Kotecha et al., 2002). Recently, it
Constructshas been shown that the TrkA receptor can be transacti-
Mutations were introduced into the wild-type (WT) sequence by
vated by the adenosine 2A (A2A) GPCR, both in PC12 PCR, using WT ApTrkl-BB4 as a template, as previously described
cells and in primary cultures of hippocampal neurons, (Nakhost et al., 1999), and moved to the pNEX3 vector as de-
scribed above.and that this transactivation does not result from release
To produce chimeric receptors, c-myc-tagged mouse TrkC plas-of NGF, the TrkA ligand, but rather requires Src activa-
mid DNA was used as a template to reamplify a fragment of thetion (Lee et al., 2002).
extracellular domain of TrkC, including the Kozak sequence, using
primers with embedded SphI sites. The amplified TrkC extracellular
Physiological Significance of ApTrkl in Facilitation fragment was then spliced into each of the ApTrkl-pNEX3 constructs
(WT, KR, and YW) using SphI, which cuts in the 5 polylinker of theA role for tyrosine kinases in long-term facilitation and
ApTrkl-pNEX3 sequence within the open reading frame near thelong-term behavioral memory has recently been demon-
transmembrane domain. The clones were then moved into the mam-strated in Aplysia (Purcell et al., 2003). This study used
malian expression vector pCMX for expression in PC12 cells.nonspecific tyrosine kinase inhibitors (Genistein) and
activators (pV) to implicate tyrosine kinases in facilitation RT-PCR
and sensitization and the activation of ERK. Here, we Total RNA was extracted using the Ambion RNAqueous 4PCR kit
identify a specific tyrosine kinase involved in LTF, (Austin, TX), and then samples were reverse transcribed into cDNA.
PCR reactions were then performed, first using primers against theApTrkl. pV activates ApTrkl strongly, and pV activation
ubiquitous housekeeping molecule, Aplysia translation factor eIF4eof both ApTrkl and ERK was strongly inhibited by both
(Dyer et al., 1998), to assess relative cDNA concentration, and thenK252a and dsRNA knockdown of this receptor. More-
approximately equal levels of cDNA were used to amplify ApTrkl,
over, 5-HT activation of ERK in the cell body and a cell- using primers P1 and P2 (see Figure 1A).
wide form of LTF were also blocked by K252a and by
dsRNA injections that specifically decreased the ex- Production of Antibodies
Four peptides from the ApTrkl clone were synthesized for immuniza-pression of ApTrkl. Thus, the receptor plays an important
tion in rabbits: two intracellular peptides (ApTrkl I1,CHLRSADSKTFrole in the standard induction protocol for LTF and may
RLNKSDLVEISV; and ApTrkl I2, CTGRSGRGRKVKGSPSR), an extra-also allow for other neurotransmitters, either ligands for
cellular peptide (ApTrkl E1, CAPGITEKPRVGDPEHG), and a phos-the receptor or alternative transactivators, to modulate
phospecific peptide [ApTrkl P1, CINKNPT(pY)FSP], each containing
memory formation after brief sensitizing stimuli. How- a cysteine residue added to the amino terminus for coupling to BSA
ever, there may be additional RTKs that play roles as maleimide and to Sulfolink columns (Pierce). Similarly, the sensorin
peptide was coupled, and chicken antibodies were then made com-well. Mammalian BDNF could replace pV in activating
5-HT Activates ApTrkl
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mercially (Gallina Biotech, Edmonton, AB, Canada). Immunization Kinase Thr202/Tyr204 (Cell Signaling, Beverly, MA). Following pri-
mary incubation, samples were washed three times for 5 min withand antibody purification has previously been described (McKay et
al., 2001; Nakhost et al., 1999). 1 PBS, and secondary incubation was then carried out in the dark
with goat-anti-rabbit CY3 and/or goat-anti-mouse CY5 or goat-anti-
mouse CY2 (Jackson Immunochemicals) at a 1:800 dilution. CellsImmunoblotting and Immunoprecipitations
were then washed three times for 5 min with 1  PBS. Finally,Homogenization of tissue, Western blotting, immunoprecipitations,
coverslips were mounted on slides with Mowial and sealed with nailand SF9 cell infection with baculovirus were performed as previously
polish. Samples were imaged using 543 nm and 633 nm wavelengthdescribed (McKay et al., 2001).
laser lines on a Zeiss LSM 510 confocal microscope, and images
were collected at 250 magnification using Zeiss LSM software.dsRNA Production
Lasers were used one at a time to ensure that there was nodsRNA was prepared using the Ambion MEGAscript RNAi kit (Austin,
bleedthrough.TX). An 800 bp region of the ApTrkl gene or of the Apror gene (McKay
et al., 2001) encoding the kinase domain was used as a template
Measurement of Change in Phosphorylationfor synthesizing the dsRNA. The Apror mRNA was chosen because
All measurements were done in a blinded fashion. For each experi-it is in the same superfamily of RTKs as ApTrkl (Figure 1B) and thus
ment, control and treated sensory cells from the same animal(s) andis a good control for the specificity of the knockdown as Apror
aliquots from the same antibody dilution were used. All images wereshows some 30%–40% homology to ApTrkl in the kinase domain.
taken using the same settings near the center of the cell whereHowever, since siRNA requires almost a perfect 21/21 bp match, it
the nucleus was well defined. The images obtained from confocalis very unlikely that even more homologous proteins, such as a
microscopy were loaded to NIH Image, and cytoplasm excludingpossible Aplysia homolog of Lymnaea Trk, would be targeted. We
the nucleus was manually outlined. The mean pixel intensity (pixelchose the kinase domain for the dsRNA because of the larger molec-
values 0–255) was then measured for the cytoplasm of each cell. Forular weight proteins observed on blots that may be alternative splice
ERK-P staining, unlike other antibodies, significant nuclear stainingforms of the receptor. If, indeed, these are the important receptors,
was seen. In this case, values were measured separately for nucleusdsRNA to the extracellular domain may not have worked. Unfortu-
and cytoplasm, but there were no significant differences betweennately, this experiment would then have been uninformative since
changes in the cytoplasm and the nucleus and thus the values werewe would not know if the dsRNA did not work because of the
merged into one average value for staining. In each experiment, thelack of knockdown of higher molecular weight forms, or for other
average pixel intensity of control cells was set to one, and all cellsnonspecific reasons. Thus, we chose a more conservative approach.
normalized to that average.
Chimera Expression in Mammalian Cells
ElectrophysiologyChimeras were expressed by lipofectamine transfection in PC12nnr5
Sensory neurons were isolated from the pleural ganglia and LFScells that do not express TrkA, as described (Bhakar et al., 1999).
motor neurons from the abdominal ganglia of 80–100 g AplysiaCells were incubated with 250 ng/ml NT3 in DMEB, washed in 1
californica. Detailed methods for culture preparation are availablePBS, and lysed in 200l of sample buffer. Samples were run on SDS-
at http://www.gonda.ucla.edu/researchlabs/martin/. After 4 days inPAGE gels and transferred to nitrocellulose, after which Western
culture, the strength of the synaptic connection between each sen-blotting was performed as described above.
sory and motor neuron was measured. No differences in the mean
initial EPSP amplitudes were observed between control and experi-Immunolocalization
mental sets. Five 5 min applications of 10 M 5-HT were given atWhole CNS (stage 11) were fixed and stained as previously de-
20 min intervals, with the cultures being washed with 50% L15/50%scribed (McKay et al., 2001). In some experiments, chicken anti-
artificial sea water during the 20 min intervals. Control cultures weresensorin was used as a costain.
treated with vehicle and washed in parallel with the 5-HT-treated
cultures. K252a (100 nM, Calbiochem, San Diego, CA) or vehicleAplysia Sensory Neuron Cultures, Functional Expression,
(0.1% DMSO) was present 30 min before, during, and 1 hr followingand dsRNA Injections
the 5-HT application. Five pulses of 5-HT were applied locally toAplysia dissociated sensory neuron cultures were prepared as pre-
the cell body, as previously described (Casadio et al., 1999). Mock-viously described (Manseau et al., 2001), plated on poly-l-lysine
treated cultures were perfused with vehicle (0.05% fast green).coated coverslips, and grown for 3 days before treatments and
K252a (100 nM) or vehicle (0.1% DMSO) was present in the bath 30fixation. In some experiments, cultured cells were injected, as de-
min before, during, and 1 hr following 5-HT stimulation. For experi-scribed (Manseau et al., 2001), with plasmid DNA encoding EGFP
ments with dsRNA, the dsRNA was injected into the sensory neuronstogether with plasmid encoding pNEX-3, pNEX-3 encoding ApTrkl,
3 days before recording (1 day after culturing) using 500 ng/l dsRNA.or pNEX-3 encoding ApTrkl KR. dsRNA was microinjected at a con-
In these experiments cells were fixed at the end of the experiment,centration ranging from 20–700 ng/l. The majority of experiments
and knockdown was confirmed by staining with the E1 antibody.used 500 ng/l. dsRNA was injected 3 days before experiments
were performed. For experiments using dsRNA injections to block 5-
AcknowledgmentsHT-mediated increases in P-ERK staining, we used sensory neurons
isolated by microdissection with sharp electrodes. This difference
This work was supported by CIHR grant MT-15121 to W.S.S., amay explain the greater increase in P-ERK staining seen in these ex-
CIHR Investigator and a Killiam and William Dawson Scholar.periments.
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